Interleukin-1 inhibitors are a class of medications designed to block the action of interleukin-1, a protein involved in the inflammatory response. By inhibiting this protein, these drugs help reduce inflammation and alleviate symptoms associated with various autoimmune and inflammatory diseases, such as rheumatoid arthritis and gout. These inhibitors can improve the quality of life for patients by decreasing pain and swelling. They are often used when other treatments are ineffective or when patients experience severe symptoms. Overall, interleukin-1 inhibitors represent an important advancement in managing chronic inflammatory conditions.